IHH in the driver's seat, analysts expect Fortis to recover in 3 quarters
IHH is planning to use the funds infused in Fortis to finance the Religare Health Trust acquisition16-11-2018
16-11-2018
IHH Healthcare review Fortis' capex, funding needs
With no plan to change the brand name, IHH Healthcare CEO Tan See Leng says his priority is to stabilize Fortis Healthcare, which still faces headwinds15-11-2018
Outcome of Board Meeting
This is in continuation to our intimation earlier today with reference number FHL/SEC/STEX/2018-19 under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015 ('LODR Regulations') regarding the (i) Preferential allotment of 23,52,94,117 Equity Shares to Northern TK Venture Pte Ltd; and (ii) Appointment of additional directors on the Board of the Company. As disclosed therein, the Board Meeting commenced at 14:20...13-11-2018
Announcement under Regulation 30 (LODR)-Meeting Updates
We wish to inform you that the Board of Directors of the Company, during the course of its meeting being conducted today, have, inter alia, considered and approved the following: 1. Allotment of 23,52,94,117 Equity Shares of the face value of Rs. 10 each through preferential issue; and 2. Appointment of additional directors13-11-2018
Malaysia's IHH likely to get control of Fortis Healthcare this week
The Fortis stock has seen an erosion of 5.4% since the deal was announced in mid-July12-11-2018
Fortis Healthcare CEO Bhavdeep Singh Resigns
On August 30, the company's Chief Financial Officer (CFO) Gagandeep Singh Bedi had resigned citing personal reasons.09-11-2018
Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
Dear Sir(s), In compliance of Regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Bhavdeep Singh, Chief Executive Officer, has resigned from his position by communication dated November 08, 2018. The Board of Directors of the Company has considered and accepted his resignation....08-11-2018
Fortis Q2 net loss widens to Rs142 crore
Fortis net loss widened to Rs142 crore in the second quarter ended September, from Rs23.61 crore a year earlier05-11-2018
Outcome of Board Meeting
This is to inform you that the Board of Directors of the Company at its meeting held on November 5, 2018, inter-alia, considered and approved Un-Audited Financial Results and Limited Review Report along with the opinion expressed by the Statutory Auditor of the Company for the quarter and period ended on September 30, 2018. Copy of the un-audited financial results, Statement of Assets & Liabilities, limited review report and press release...05-11-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
This is with reference to your mail dated today and the recent news item which appeared in Economics Times on October 30, 2018, captioned " Competition Commission of India approves IHH Healthcare''s acquisition of Fortis.' In this regard, it is clarified that the application to the Competition Commission of India ('CCI') has been made by the investor - namely Northern TK Venture Pte. Ltd, Singapore...01-11-2018